Real-time enrollment status for this idiopathic pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 6:33 PM UTC
| NCT Number | NCT07868419 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Pulmonary Fibrosis |
| Phase | PHASE3 |
| Target Enrollment | 201 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Trevi Therapeutics |
| Last Updated on CT.gov | October 9, 2026 (6 days ago) |
As of October 15, 2026: Clinical trial NCT07868419 is currently recruiting participants. This phase3 study for idiopathic pulmonary fibrosis is actively seeking new participants at 4 locations across the United States. The study is sponsored by Trevi Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07868419 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07868419 was last updated 6 days ago (October 9, 2026). HelloStudys verifies this status automatically.